AKTS - Aktis Oncology, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$31.00
DETAILS
HIGH:
$31.00
LOW:
$31.00
MEDIAN:
$31.00
CONSENSUS:
$31.00
UPSIDE:
100.13%
Market Cap:
825.57M
Volume:
576,787
Avg Volume:
406,255
52 Week Range:
15.44-29.16
Sector:
Healthcare
Industry:
Biotechnology
Beta:
N/A
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
N/A
IPO Date:
2026-01-09
EPS (TTM):
N/A
P/E Ratio:
N/A
Revenue (TTM):
1.49M
Total Assets:
279.04M
Total Debt:
11.87M
Cash & Equiv:
180.25M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-16.9%
Debt/Equity:
-0.14
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-25 | $-60.17 | — | — | $4.6M | — | — |
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 1.49M | 0 | 0 |
| Net Income | (43.98M) | (28.64M) | (17.93M) |
| EPS | 0.00 | 0.00 | 0.00 |
| Total Assets | 326.18M | 122.36M | 138.32M |
| Total Debt | 12.01M | 13.40M | 1.77M |
| Cash & Equivalents | 37.16M | 29.51M | 128.60M |
| Operating Cash Flow | 14.76M | (30.00M) | (18.12M) |
| Free Cash Flow | 11.90M | (33.77M) | (20.43M) |
| FCF per Share | N/A | N/A | N/A |
| Book Value | (87.80M) | (46.31M) | (19.23M) |
| Cash & ST Investments | 297.17M | 97.86M | 128.60M |
| ROC Equity | N/A | N/A | N/A |